Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations

v3.7.0.1
Consolidated Statements of Operations - USD ($)
3 Months Ended
Feb. 28, 2017
Feb. 29, 2016
Revenues:    
Sales of health and beauty aid products - net $ 4,265,078 $ 4,680,272
Other income 4,073 4,172
Total Revenues 4,269,151 4,684,444
Costs and Expenses:    
Cost of sales 1,707,854 1,814,794
Selling, general and administrative expenses 1,625,378 2,073,975
Advertising, cooperative and promotional expenses 482,215 316,906
Research and development 13,082 8,201
Bad debt (recovery) expense (9,931) 810
Interest expense - related party 0 3,085
Interest expense 151,161 125,511
Total Costs and Expenses 3,969,759 4,343,282
Income before Provision for Income Taxes 299,392 341,162
Provision for Income taxes 112,640 132,222
Income from Continuing Operations 186,752 208,940
Discontinued Operations    
(Loss) from Discontinued Operations 0 (9,096)
(Benefit from) income taxes 0 (3,525)
(Loss) from Discontinued Operations 0 (5,571)
Net Income $ 186,752 $ 203,369
Basic    
Continuing Operations (usd per share) $ 0.03 $ 0.03
Discontinued Operations (usd per share) 0 0
Income (usd per share) 0.03 0.03
Diluted    
Continuing Operations (usd per share) 0.03 0.03
Discontinued Operations (usd per share) 0 0
Income (usd per share) $ 0.03 $ 0.03
Weighted Average Common Shares Outstanding    
Basic (shares) 7,006,684 7,006,684
Diluted (shares) 7,006,684 7,047,765